Label Image (Lbl530026643)
Losartan Potassium
Product Images NDC 53002-6643
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 53002-6643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Losartan Fig1)
Figure 2 (Losartan Fig2)
From the given text, it appears to be a description related to a study on the effectiveness of Atenolol and Losartan Potassium Tablets in reducing the risk of fatal/non-fatal stroke in patients. The study shows an adjusted risk reduction of 25% with a p-value of 0.001. The study duration is mentioned in terms of months (from 6 to 66 months).*
Figure 3 (Losartan Fig3)
Figure 4 (Losartan Fig4)
This text appears to be a data table displaying the number of patients with an event, risk reduction percentage, and a p-value for a comparison between Losartan Potassium Tablets and Placebo. The table also shows a time period of 12, 24, 36, and 48.*
Losartan-str.jpg (Losartan Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
